BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 10770220)

  • 1. Somatostatin receptor subtypes in human thymoma and inhibition of cell proliferation by octreotide in vitro.
    Ferone D; van Hagen MP; Kwekkeboom DJ; van Koetsveld PM; Mooy DM; Lichtenauer-Kaligis E; Schönbrunn A; Colao A; Lamberts SW; Hofland LJ
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1719-26. PubMed ID: 10770220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo and in vitro expression of somatostatin receptors in two human thymomas with similar clinical presentation and different histological features.
    Ferone D; Kwekkeboom DJ; Pivonello R; Bogers ADColao A; Lamberts SW; van Hagen PM; Hofland LJ
    J Endocrinol Invest; 2001; 24(7):522-8. PubMed ID: 11508787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro characterization of somatostatin receptors in the human thymus and effects of somatostatin and octreotide on cultured thymic epithelial cells.
    Ferone D; van Hagen PM; van Koetsveld PM; Zuijderwijk J; Mooy DM; Lichtenauer-Kaligis EG; Colao A; Bogers AJ; Lombardi G; Lamberts SW; Hofland LJ
    Endocrinology; 1999 Jan; 140(1):373-80. PubMed ID: 9886848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin receptor scintigraphy in thymoma imaging method and clinical application.
    Marienhagen J; Schalke B; Aebert H; Held P; Eilles C; Bogdahn U
    Pathol Res Pract; 1999; 195(8):575-81. PubMed ID: 10483589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thymoma and somatostatin analogs. Biology, diagnostic and clinical practice].
    Palmieri G; Montella L; Lastoria S
    Minerva Endocrinol; 2001 Sep; 26(3):193-5. PubMed ID: 11753243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo localization of [(111)In]-DTPA-D-Phe1-octreotide to human ovarian tumor xenografts induced to express the somatostatin receptor subtype 2 using an adenoviral vector.
    Rogers BE; McLean SF; Kirkman RL; Della Manna D; Bright SJ; Olsen CC; Myracle AD; Mayo MS; Curiel DT; Buchsbaum DJ
    Clin Cancer Res; 1999 Feb; 5(2):383-93. PubMed ID: 10037188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo detection of functional somatostatin receptors in canine insulinomas.
    Robben JH; Visser-Wisselaar HA; Rutteman GR; van Rijk PP; van Dongen AJ; Voorhout G; van den Ingh TS; Hofland LJ; Lamberts SW
    J Nucl Med; 1997 Jul; 38(7):1036-42. PubMed ID: 9225787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [111In-DTPA-D-Phe1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation.
    Bakker WH; Albert R; Bruns C; Breeman WA; Hofland LJ; Marbach P; Pless J; Pralet D; Stolz B; Koper JW
    Life Sci; 1991; 49(22):1583-91. PubMed ID: 1658515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo detection of malignant thymic masses by indium-111-DTPA-D-Phe1-octreotide scintigraphy.
    Lastoria S; Vergara E; Palmieri G; Acampa W; Varrella P; Caracò C; Bianco RA; Muto P; Salvatore M
    J Nucl Med; 1998 Apr; 39(4):634-9. PubMed ID: 9544670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new radiolabelled somatostatin analogue [111In-DTPA-D-Phe1]RC-160: preparation, biological activity, receptor scintigraphy in rats and comparison with [111In-DTPA-D-Phe1]octreotide.
    Breeman WA; Hofland LJ; van der Pluijm M; van Koetsveld PM; de Jong M; Setyono-Han B; Bakker WH; Kwekkeboom DJ; Visser TJ; Lamberts SW
    Eur J Nucl Med; 1994 Apr; 21(4):328-35. PubMed ID: 7911760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo evaluation of copper-64-octreotide conjugates.
    Anderson CJ; Pajeau TS; Edwards WB; Sherman EL; Rogers BE; Welch MJ
    J Nucl Med; 1995 Dec; 36(12):2315-25. PubMed ID: 8523125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin receptors in the thymus.
    Ferone D; van Hagen PM; Colao A; Annunziato L; Lamberts SW; Hofland LJ
    Ann Med; 1999 Oct; 31 Suppl 2():28-33. PubMed ID: 10574152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo detection of somatostatin receptors in human malignant lymphomas.
    Reubi JC; Waser B; van Hagen M; Lamberts SW; Krenning EP; Gebbers JO; Laissue JA
    Int J Cancer; 1992 Apr; 50(6):895-900. PubMed ID: 1348240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical detection of somatostatin receptor subtypes sst1 and sst2A in human somatostatin receptor positive tumors.
    Hofland LJ; Liu Q; Van Koetsveld PM; Zuijderwijk J; Van Der Ham F; De Krijger RR; Schonbrunn A; Lamberts SW
    J Clin Endocrinol Metab; 1999 Feb; 84(2):775-80. PubMed ID: 10022452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pituitary uptake of (111)In-DTPA-D-Phe1-octreotide in the normal pituitary and in pituitary adenomas.
    Colao A; Lastoria S; Ferone D; Varrella P; Marzullo P; Pivonello R; Cerbone G; Acampa W; Salvatore M; Lombardi G
    J Endocrinol Invest; 1999 Mar; 22(3):176-83. PubMed ID: 10219884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin receptor scintigraphy and somatostatin therapy in the evaluation and treatment of malignant thymoma.
    Lin K; Nguyen BD; Ettinger DS; Chin BB
    Clin Nucl Med; 1999 Jan; 24(1):24-8. PubMed ID: 9890489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative studies on the expression of somatostatin receptor subtypes, outcome of octreotide scintigraphy and response to octreotide treatment in patients with carcinoid tumours.
    Nilsson O; Kölby L; Wängberg B; Wigander A; Billig H; William-Olsson L; Fjälling M; Forssell-Aronsson E; Ahlman H
    Br J Cancer; 1998 Feb; 77(4):632-7. PubMed ID: 9484822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional imaging of thymic disorders.
    Lastoria S; Palmieri G; Muto P; Lombardi G
    Ann Med; 1999 Oct; 31 Suppl 2():63-9. PubMed ID: 10574158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear localization of 111In after intravenous injection of [111In-DTPA-D-Phe1]-octreotide in patients with neuroendocrine tumors.
    Janson ET; Westlin JE; Ohrvall U; Oberg K; Lukinius A
    J Nucl Med; 2000 Sep; 41(9):1514-8. PubMed ID: 10994731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Internalization of indium-111 into human neuroendocrine tumor cells after incubation with indium-111-DTPA-D-Phe1-octreotide.
    Andersson P; Forssell-Aronsson E; Johanson V; Wängberg B; Nilsson O; Fjälling M; Ahlman H
    J Nucl Med; 1996 Dec; 37(12):2002-6. PubMed ID: 8970523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.